Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Net Cash Flow (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Net Cash Flow readings, the most recent being $5.1 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 89.09% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$47.5 million, a 206.99% decrease, with the full-year FY2025 number at -$5.5 million, up 88.49% from a year prior.
  • Net Cash Flow hit $5.1 million in Q4 2025 for Enanta Pharmaceuticals, up from -$12.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $52.6 million in Q3 2021 to a low of -$72.5 million in Q2 2021.
  • Median Net Cash Flow over the past 5 years was -$156500.0 (2022), compared with a mean of -$745300.0.
  • Biggest five-year swings in Net Cash Flow: surged 513.43% in 2021 and later tumbled 2466.63% in 2023.
  • Enanta Pharmaceuticals' Net Cash Flow stood at $41.9 million in 2021, then plummeted by 104.23% to -$1.8 million in 2022, then tumbled by 2466.63% to -$45.5 million in 2023, then surged by 203.65% to $47.1 million in 2024, then plummeted by 89.09% to $5.1 million in 2025.
  • The last three reported values for Net Cash Flow were $5.1 million (Q4 2025), -$12.5 million (Q3 2025), and -$15.4 million (Q2 2025) per Business Quant data.